Bone Biologics Corporation filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Weinberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +0.72% |
|
-2.40% | -73.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.01% | 13.43L | |
+13.62% | 13TCr | |
-8.93% | 1.08TCr | |
-18.14% | 712.39Cr | |
+48.89% | 646.11Cr | |
-34.21% | 397.62Cr | |
+8.03% | 343Cr | |
-18.50% | 190.75Cr | |
-24.94% | 166.31Cr | |
-36.36% | 147.16Cr |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Auditor Raises 'Going Concern' Doubt